The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In vivo soluble α-synuclein occurs as a monomer and several multimers, the latter of which may be important for the biological function of α-synuclein. Currently, there is a lack of reproducible methods to compare α-synuclein multimer abundance between complex biological samples. Here we developed a method, termed “multimer-PAGE,” that combines in-gel chemical cross-linking with several common electrophoretic techniques to measure the stoichiometry of soluble α-synuclein multimers in brain tissue lysates. Results show that soluble α-synuclein from the rat brain exists as several high molecular weight species of approximately 56 kDa (αS56), 80 kDa...
Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy are disorders featuring a...
The α-synuclein protein exists in vivo in a variety of covalently modified and aggregated forms asso...
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkins...
The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In v...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
The pathophysiology of Parkinson’s disease is characterized by the abnormal accumulation of α-synucl...
It is now widely recognised that α-Synuclein (αSyn) oligomers are the main pathogenic species in Pa...
Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder...
Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder...
β-Sheet-rich aggregates of α-synuclein (αSyn) are the hallmark neuropathology of Parkinson's disease...
Genetic, biochemical, and animal model studies strongly suggest a central role for α-synuclein in th...
Monomeric α-synuclein (αSN) species are abundant in nerve terminals where they are hypothesized to p...
γ-Synuclein is expressed at high levels in neuronal cells and in multiple invasive cancers. Like its...
Parkinson’s disease (PD) is characterized by intraneuronal inclusions of aggregated α-synuclein prot...
Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy are disorders featuring a...
The α-synuclein protein exists in vivo in a variety of covalently modified and aggregated forms asso...
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkins...
The aberrant aggregation of α-synuclein in the brain is a hallmark of Parkinson’s disease (PD). In v...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
Despite two decades of research, the structure–function relationships of endogenous, physiological f...
The pathophysiology of Parkinson’s disease is characterized by the abnormal accumulation of α-synucl...
It is now widely recognised that α-Synuclein (αSyn) oligomers are the main pathogenic species in Pa...
Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder...
Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder...
β-Sheet-rich aggregates of α-synuclein (αSyn) are the hallmark neuropathology of Parkinson's disease...
Genetic, biochemical, and animal model studies strongly suggest a central role for α-synuclein in th...
Monomeric α-synuclein (αSN) species are abundant in nerve terminals where they are hypothesized to p...
γ-Synuclein is expressed at high levels in neuronal cells and in multiple invasive cancers. Like its...
Parkinson’s disease (PD) is characterized by intraneuronal inclusions of aggregated α-synuclein prot...
Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy are disorders featuring a...
The α-synuclein protein exists in vivo in a variety of covalently modified and aggregated forms asso...
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkins...